Skip to content
TrackPodcasts
newsMar 11, 20260:58

New Non-Hormonal Menopause Drug on NHS

About this episode

New Non-Hormonal Menopause Drug on NHS

Get every episode summarized

Each time UK News Today | 2 Min News | The Daily News Now! publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

Transcript ready

14 searchable segments. Every word is indexed and playable.

New Non-Hormonal Menopause Drug on NHS

UK News Today | 2 Min News | The Daily News Now!

0:00
0:58

Full transcript

UK News Today | 2 Min News | The Daily News Now!New Non-Hormonal Menopause Drug on NHS. Machine-transcribed; use the interactive transcript above to jump the player to any line.

On March 11th, over 500,000 women in England can now access a new drug on the NHS to ease menopausal hot flushes and night sweats. Called Vioza or Fezalinitin, it's approved for those who can't use hormone replacement therapy. Earlier this week, the National Institute for Health and Care Excellence gave it the go-ahead after reviewing strong evidence. Unlike HRT, this non-hormonal option works by blocking brain signals that cause the symptoms. For years, women with issues like breast cancer history, blood clots, or high blood pressure had few choices beyond HRT, which isn't right for everyone. These hot flushes often disrupt daily life and sleep badly. NHS leaders say it's a game changer, offering real relief and good value for money. The once daily 45-mg tablet should help many fill more in control. With HRT still the top pick for most, this adds a key backup, bringing better options to those who need them most.

More episodes

More from UK News Today | 2 Min News | The Daily News Now!

View all episodes →